Phase 3 Readout~month

Phase 3 Topline: A Single Center, Open Label, Expanded Access Study of QRX003 Lotion in Subjects With Netherton Syndr

Drug
qrx003
Indication
Netherton Syndrome

Other upcoming events for QNRX

Phase 3 ReadoutPhase 3 Topline: A Multicenter, Randomized, Vehicle-Controlled, Double-Blind, Parallel Comparison Study of QRX003 Lot
Phase 3 ReadoutPhase 3 Topline: A Multicenter, Open-label Study of QRX003 Lotion in Participants With Netherton Syndrome

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: A Single Center, Open Label, Expanded Access Study of QRX003 Lotion in Subjects With Netherton Syndr — QNRX Phase 3 Readout | BioSniper